The stepwise approach to the management of type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 65, Issue SUPPL., 2004, Pages S3-

  Warren, Roderick E ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Diabetes mellitus; Insulin; Management; Nutrition; Oral agents; Therapy

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE; CHLORPROPAMIDE; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; GLIPIZIDE; HEMOGLOBIN A1C; INSULIN; METFORMIN; MIGLITOL; NATEGLINIDE; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA; TOLBUTAMIDE;

BODY WEIGHT DISORDER; CARDIOVASCULAR DISEASE; COMORBIDITY; DIET; DOSE RESPONSE; DRUG ACTIVITY; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; GLUCOSURIA; HEART INFARCTION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; HYPOGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; KIDNEY DISEASE; LACTIC ACIDOSIS; LIFESTYLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATIENT COMPLIANCE; PATIENT COUNSELING; PHYSICAL ACTIVITY; REVIEW; WEIGHT REDUCTION;

EID: 4143102453     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2004.07.002     Document Type: Article

References (44)

1. National Institute of Diabetes & Digestive & Kidney Diseases, National Diabetes Statistics Fact Sheet: General Information and National Estimates on Diabetes in the United States, vol. 2000, 2002.
2. M.I. Harris Diabetes in America: epidemiology and scope of the problem Diab. Care 21 Suppl. 3 1998 C11 C14
3. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025 Diab. Care 21 1998 1414 1431
4. E. Ferrannini Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects Endocr. Rev. 19 1998 477 490
5. Y. Ohkubo, H. Kishikawa, E. Araki, T. Miyata, S. Isami, and S. Motoyoshi Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study Diabetes Res. Clin. Pract. 28 1995 103 117
6. Diabetes Control and Complications Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N. Engl. J. Med. 329 1993 977 986
7. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
8. American College of Endocrinology American College of Endocrinology Consensus Statement on Guidelines for Glycemic Control Endocr. Pract. 8 Suppl. 1 2002 5 11
9. American Diabetes Association Standards of medical care for patients with diabetes mellitus Diab. Care 26 2003 S33 S50
10. Nutrition Therapy: Canadian Diabetes Association Clinical Guidelines Expert Committee, 2003, http://www.diabetes.ca/cpg2003/downloads/nutrition.pdf,.
11. UK Prospective Diabetes Study Group Overview of 6 years' therapy of type II diabetes: a progressive disease (UKPDS 16) Diabetes 44 1995 1249 1258
12. American Diabetes Association Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications Diab. Care 26 1 2003 S51 S61
13. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N. Engl. J. Med. 346 2002 393 403
14. S.E. Inzucchi Oral antihyperglycemic therapy for type 2 diabetes J. Am. Med. Assoc. 287 2002 360 372
15. C. Mensing, J. Boucher, M. Cypress, K. Weinger, K. Mulcahy, and P. Barta National standards for diabetes self-management education, Task Force to Review and Revise the National Standards for Diabetes Self-Management Education Programs Diab. Care 23 2000 682 689
16. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
17. R. Perfetti, and A. Ahmad Novel sulfonylurea and non-sulfonylurea drugs to promote the secretion of insulin Trends Endocrinol. Metab. 11 2000 218 223
18. T. Levien, D.E. Baker, R.K. Campbell, and J.R. White Nateglinide therapy for type 2 diabetes Ann. Pharmacother. 35 2001 1426 1434
19. A. Parulkar, M. Pendergrass, R. Granda-Ayala, T. Lee, and V. Fonseca Non-hypoglycemic effects of thiazolidinediones Ann. Intern. Med. 134 2001 61 71
20. E. Horton, F. Whitehouse, M.N. Ghazzi, T. Venable, R.W. Whitcomb The Troglitazone Study Group Troglitazone in combination with sulfonylureas restores glycemic control in patients with type 2 diabetes Diab. Care 21 1998 1462 1469
21. A.H. Barnett Insulin-sensitizing agents - thiazolidinediones (glitazones) Curr. Med. Res. Opin. 18 2002 S31 S39
22. I.E. Kelly, T.S. Han, K. Walsh, and M.E. Lean Effects of a thiazolidinedione compound on body fat and fat distribution in patients with type 2 diabetes Diab. Care 22 1999 288 293
23. E.J. Murphy, D.T.J.A.O. Shakil, L. Shick, U. Masharani, H. Chow Acute Liver Failure Study Group Troglitazone-induced fulminant hepatic failure Dig. Dis. Sci. 45 2000 549 553
24. B.H. Wolffenbuttel, R. Gomis, S. Squatrito, N.P. Jones, and R.N. Patwardhan Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in type 2 diabetic patients Diab. Med. 17 2000 40 47
25. D. Einhorn, M. Rendell, J. Rosenzweig, J.W. Egan, A.L. Mathisen, R.L. Schneider The Pioglitazone 027 Study Group Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study Clin. Ther. 22 2000 1395 1409
26. V. Fonseca, J. Rosenstock, R.N. Patwardhan, and A. Salzman Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial J. Am. Med. Assoc. 283 2000 1695 1702
27. A.J. Garber, J. Larsen, S.H. Schneider, B.A. Piper, D. Henry Glyburide/Metformin Initial Therapy Study Group Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes Diab. Obes. Metab. 4 2002 201 208
28. J.F. Yale, T.R. Valiquett, M.N. Ghazzi, J.K. Owens-Grillo, R.W. Whitcomb, and H.L. Foyt The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin: a multicenter, randomized, double-blind, placebo-controlled trial Ann. Intern. Med. 134 2001 737 745
29. S. Schwartz, R. Sievers, P. Strange, W.H. Lyness, P. Hollander INS-2061 Study Team Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis Diab. Care 26 2003 2238 2243
30. K. Malmberg DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group Prospective randomised study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus BMJ 314 1997 1512 1515
31. M.C. Riddle The underuse of insulin therapy in North America Diab. Metab. Res. Rev. 18 2002 S42 S49
32. J.A. Scarlett, R.S. Gray, J. Griffin, J.M. Olefsky, and O.G. Kolterman Insulin treatment reverses the insulin resistance of type II diabetes mellitus Diab. Care 5 1982 353 363
33. W.J. Andrews, B. Vasquez, M. Nagulesparan, I. Klimes, J. Foley, and R. Unger Insulin therapy in obese, non-insulin-dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal Diabetes 33 1984 634 642
34. W.T. Garvey, J.M. Olefsky, J. Griffin, R.F. Hamman, and O.G. Kolterman The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus Diabetes 34 1985 222 234
35. S. Makimattila, K. Nikkila, and H. Yki-Jarvinen Causes of weight gain during insulin therapy with and without metformin in patients with non-insulin-dependent diabetes Diabetologia 42 1999 406 412
36. E. Larger, P. Rufat, D. Dubois-Laforgue, and S. Ledoux Insulin therapy does not itself induce weight gain in patients with type 2 diabetes Diab. Care 24 2001 1849 1850
37. J. Rosenstock, S.L. Schwartz, C.M. Clark Jr., G.D. Park, D.W. Donley, and M.B. Edwards Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin Diab. Care 24 2001 631 636
38. A. Fritsche, M.A. Schweitzer, H.-U. Haring The 4001 Study Group Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes Ann. Intern. Med. 138 2003 952 959
39. M.C. Riddle, J. Rosenstock, J. Gerich the Insulin Glargine 4002 Study Investigators The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients Diab. Care 26 2003 3080 3086
40. J.L. Johnson, S.L. Wolf, and U.M. Kabadi Efficacy of insulin and sulfonylurea combination therapy in type 2 diabetes: a meta-analysis of the randomized placebo-controlled trials Arch. Intern. Med. 156 1996 259 264
41. H. Yki-Jarvinen Combination therapies with insulin in type 2 diabetes Diab. Care 24 2001 758 767
42. J.G. Yu, Y.T. Kruszynska, M.I. Mulford, and J.M. Olefsky A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients Diabetes 48 1999 2414 2421
43. S.A. Segel, D.S. Paramore, and P.E. Cryer Hypoglycemia-associated autonomic failure in advanced type 2 diabetes Diabetes 51 2002 724 733
44. D.A. Hepburn, K.M. MacLeod, A.C. Pell, I.J. Scougal, and B.M. Frier Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin Diab. Med. 10 1993 231 237